Genesys Capital

Summary

Genesys Capital is the famous VC, which was founded in 2000. The company was established in North America in Canada. The leading representative office of defined VC is situated in the Toronto.

This organization was formed by Damian Lamb, Kelly Holman. The overall number of key employees were 4.

Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Medical Device, Medical. Among the most popular portfolio startups of the fund, we may highlight Fusion Pharmaceuticals, Tioga Pharmaceuticals, NeurAxon. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Canada. The fund has exact preference in some founders of portfolio startups. If startup sums 3 of the founder, the chance for it to be financed is low.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Genesys Capital, startups are often financed by Adams Street Partners, TPG Biotech, PathoCapital. The meaningful sponsors for the fund in investment in the same round are Adams Street Partners, TPG Biotech, PathoCapital. In the next rounds fund is usually obtained by OrbiMed, Adams Street Partners, Varian Medical Systems.

Considering the real fund results, this VC is 10 percentage points less often commits exit comparing to other organizations. Opposing the other organizations, this Genesys Capital works on 14 percentage points less the average amount of lead investments. The high activity for fund was in 2018. Despite it in 2019 the fund had an activity. The top amount of exits for fund were in 2015. The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 10 - 50 millions dollars.